Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Verici Dx (VRCI) Share Price

Price 0.40p on 09-06-2026 at 05:00:12
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Last Trade: Buy 11,135.00 at 0.40p
Day's Volume: 0
Last Close: 0.40p
Open: 0.00p
ISIN: GB00BM8HZD43
Day's Range 0.00p - 0.00p
52wk Range: 0.375p - 1.375p
Market Capitalisation: £6.05m
VWAP: 0.00p
Shares in Issue: 1.51b

Verici Dx (VRCI) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 11,135 0.40p Suspected BUY Trade
16:35:08 - 08-Jun-26
Buy* 15,830 0.385p Ordinary
16:29:52 - 08-Jun-26
Sell* 4,310 0.3505p Ordinary
15:00:11 - 08-Jun-26
Buy* 55,563 0.387p Ordinary
14:57:47 - 08-Jun-26
Sell* 1,110,807 0.37p Ordinary
14:56:44 - 08-Jun-26
Sell* 803 0.352p Ordinary
14:30:24 - 08-Jun-26
Sell* 357,971 0.3565p Ordinary
12:51:15 - 08-Jun-26
Sell* 1,500,000 0.37p Ordinary
12:26:20 - 08-Jun-26
Sell* 140,000 0.3565p Ordinary
12:12:36 - 08-Jun-26
Buy* 4,129 0.40p Ordinary
12:02:52 - 08-Jun-26
See more Verici Dx trades

Verici Dx (VRCI) Share Price History

Time period:
to
Date Open High Low Close Volume
8th Jun 2026 (Mon) 0.375 0.40 0.40 0.40 3,649,512
5th Jun 2026 (Fri) 0.425 0.425 0.375 0.375 11,255,018
4th Jun 2026 (Thu) 0.425 0.425 0.425 0.425 980,795
3rd Jun 2026 (Wed) 0.425 0.425 0.425 0.425 2,543,262
2nd Jun 2026 (Tue) 0.475 0.475 0.425 0.425 1,327,800
1st Jun 2026 (Mon) 0.425 0.425 0.425 0.425 577,238
29th May 2026 (Fri) 0.425 0.425 0.425 0.425 811,008
28th May 2026 (Thu) 0.425 0.425 0.425 0.425 21,255
27th May 2026 (Wed) 0.425 0.425 0.425 0.425 513,122
26th May 2026 (Tue) 0.425 0.425 0.425 0.425 1,791,187
25th May 2026 (Mon) 0.425 0.425 0.425 0.425 0
22nd May 2026 (Fri) 0.425 0.425 0.425 0.425 20,369
21st May 2026 (Thu) 0.425 0.425 0.425 0.425 526,022
20th May 2026 (Wed) 0.425 0.425 0.425 0.425 152,226
19th May 2026 (Tue) 0.475 0.475 0.425 0.425 2,329,033
18th May 2026 (Mon) 0.45 0.45 0.425 0.425 2,372,641
15th May 2026 (Fri) 0.45 0.45 0.45 0.45 59,138
14th May 2026 (Thu) 0.45 0.45 0.45 0.45 575,512
13th May 2026 (Wed) 0.475 0.475 0.475 0.475 1,346,758
12th May 2026 (Tue) 0.475 0.475 0.475 0.475 498,176
11th May 2026 (Mon) 0.475 0.475 0.475 0.475 3,054,749
See more Verici Dx price history

Verici Dx (VRCI) Regulatory News

Date Source Headline
8th Jun 2026 1:52 pm RNS Publication of Circular & Notice of GM
8th Jun 2026 7:00 am RNS WRAP Retail Offer for up to £200,000
5th Jun 2026 5:41 pm RNS Result of Placing & raising gross proceeds c£2.5m
5th Jun 2026 11:40 am RNS Proposed Fundraising via Placing
4th Jun 2026 3:40 pm RNS Holding(s) in Company
2nd Jun 2026 12:41 pm RNS Holding(s) in Company
2nd Jun 2026 7:00 am RNS AMA grants additional CPT® Code for ProtegaTM
2nd Jun 2026 7:00 am RNS-R Study validating economic advantages of PTRA test
27th May 2026 4:04 pm RNS Holding(s) in Company
22nd May 2026 3:53 pm RNS Holding(s) in Company
See more Verici Dx regulatory news

Verici Dx (VRCI) Share News

TRADING UPDATES: Unicorn Mineral; Helix Exploration agree acquisitions

8th Jun 2026 15:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News: Read More

IN BRIEF: Verici Dx says study validates PTRA in kidney transplants

19th May 2026 16:16

Verici Dx PLC - Cardiff, Wales-based developer of advanced clinical diagnostics for organ transplants - Announces the publication of a peer-reviewed clinical validation study of its pre-transplant rejection assessment test, which is commercially marketed by Thermo Fisher Scientific Inc. Says the test outperformed conventional risk assessment tools in the ability to predict early acute rejection in the first two months following a kidney transplant, which enables clinicians to identify patients who may benefit from the safe minimisation of therapy while effectively managing the risk of early rejection. Says current methods, which involve standardised immunosuppressive regimens with more aggressive therapy for patients seen as high-risk, "have limited predictive value, which can lead to unnecessary over-suppression and risks related to toxicity, infections and malignancy." Read More

WINNERS & LOSERS: Riverstone redeems shares; IQE raises GBP513 million

28th Apr 2026 11:20

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

EARNINGS AND TRADING: Norcros sales up; eEnergy eyes record first-half

16th Apr 2026 14:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

WINNERS & LOSERS: Animalcare agrees to bid; Alumasc lowers forecast

16th Apr 2026 12:02

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More

See more Verici Dx news
FTSE 100 Latest
Value10,373.20
Change5.15

Login to your account

Forgot Password?

Not Registered